KURA ONCOLOGY INC. - COMMON STOCK
7,3200
10-января-25 16:45:00
15 мин. задержка
Акции
-0,4600
-5,91%
Сегодняшний диапазон
7,1750 - 7,7286
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
23 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology
30 сен 2024 18:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors
17 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Cantor Global Healthcare Conference
10 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology Reports Second Quarter 2024 Financial Results
08 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
08 авг 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology to Report Second Quarter 2024 Financial Results
01 авг 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 июл 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes
24 июн 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 июн 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Jefferies Global Healthcare Conference
29 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
14 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
08 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology Reports First Quarter 2024 Financial Results
02 май 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology to Report First Quarter 2024 Financial Results
25 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
22 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Stifel Targeted Oncology Forum
10 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
NetDania - New 12 months High: KURA ONCOLOGY INC. - COMMON STOCK
11 мар 2024 09:53:56 Источник NetDania Notify